Lung Cancer Flashcards

1
Q

Staging for NSCLC

A

Use TNM

T1 = 1-3cm

T2 = 3-5cm

T3 = 5-7cm

T4 = >7cm

N1 = lung or hilar lymph nodes

N2 = ipsilateral mediastinum lymph nodes or under carina

N3 = lymph nodes contralateral to affected side, in supraclavicular fossa or at apex of lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Staging for SCLC

A

Limited = 1 lung

Extensive = both lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 types of NSCLC

A

Squamous cell

Adenocarcinoma

Large cell

Carcinoid tumours

Bronchoalveolar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the prevalence + characteristics of squamous cell cancer?

A

42% of NSCLC

Large lesion centrally (bronchus), leading to infection

Closely linked with smoking

Can secrete PTH relate peptide - leading to malignancy related hypercalcaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the prevalence + characteristics of adenocarcinoma?

A

30% of NSCLC

Contains mucus cells

Often brain + bone mets

Seen in non-smokers, associated with asbestos

Arises in peripheral areas of the lung

More frequent in women

Associated with activating mutations in EGFR + ALK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the prevalence + characteristics of large cell lung cancer?

A

8% of NSCLC

Mets early

Less differentiated

Generally small tumours, in people under 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the characteristics of carcinoid tumours?

A

Most indolent type - unrelated to smoking

Can metastasize

Secrete serotonin which increases peristalsis + causes diarrhoea + can cause bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do broncoalveolar cell cancers look like?

A

Peripheral solidary nodule or diffuse nodular lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the prevalence + characteristics + management of small cell carcinomas?

A

20% of lung cancer

Strong link to smoking + uranium mining

Arise from Kulchitsky cells

Rapidly growing + highly malignant

Chemotherapy often only option. No role for radiotherapy due to pneumonitis

Associated with paraneoplastic syndromes, causing SIADH, Cushings, Lambert Eaton Myesthaenic syndrome (LEMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the characteristics of mesotheliomas?

A

Cancer of pleura

Extremely asbestos related

Recurrent pleural effusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Epidemiology - what % of cancers are lung, how many deaths are caused

A

13% of cancers + 22% of cancer deaths

Bronchial carcinoma = 95% of all lung cancers

M:F = 3:1

1 in every 13 men

1 in every 15 women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

RF

A

Smoking

Increasing age

COPD

Epidermal growth factor receptor

Genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Symptoms

A

Cough, haemoptysis, dyspnoea, chest pain, recurrent pneumonia, lethargy, anorexia, weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Signs

A

Cachexia, anaemia, clubbing, HPOA (hypertrophic pulmonary osteoarthropathy causing wrist pain)

Supraclavicular nodes, Horner’s syndrome

Consolidation, collapse, pleural effusion

Paraneoplastic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Paraneoplastic symptoms

A

Most often due to SCLC but can also be due to NSCLC

Hypercalcemia due to parathyroid-like hormone production occurs most commonly in patients with SCCs

Clubbing and hypertrophic pulmonary osteoarthropathy and Trousseau syndrome of hypercoagulability are caused more frequently by adenocarcinomas

The syndrome of inappropriate antidiuretic hormone production (SIADH) is more common in SCLC but can also occur in NSCLC.

Cushing syndrome from ectopic adrenocorticotropic hormone (ACTH) production is more likely to occur in SCLC or bronchial carcinoid

Lambert Eaton syndrome – autoimmune against the neuromuscular junction usually SCLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Common mets

A

Lymph nodes, brain, bones, liver, adrenal glands

17
Q

Other types of tumour

A

Bronchial adenoma (rare, slow growing, 90% carcinoid, 10% cylindromas)

Hamartoma (rare, benign, CT lobulated mass with flecks of calcification)

Mesothelioma (cancer of pleura)

18
Q

Investigations for staging

A

CXR Cytology (sputum + pleural fluid)

CT to stage tumour

Bronchoscopy for histology +- endobronchial

US PET scan to check distant mets

Tumour markers = NSE + LDH

Pulmonary function tests

19
Q

Findings on CXR of lung cancer

A

Peripheral nodule, hilar enlargement, consolidation, lung collapse, pleural effusion, bony secondaries

20
Q

Staging assessment - bloods + imaging

A

Serum lactate dehydrogenase, LFTs + serum sodium

CT of chest, liver + adrenal glands

21
Q

10 year overall + 5 year survival rates for NSCLC/ SCLC based on stages 1 or 4

A

10 year = 5.5%

NSCLC = 92% for stage 1 to 1% for stage 4

SCLC = 31% stage 1 to 2% stage 4

22
Q

Treatment of NSCLC by stage

A

Stage 1/2 = excision, adjuvant chemo + RT.

Curative RT if not suitable for surgery

Stage 3 = lobectomy/ pneumonectomy + adjuvant chemo/ radiotherapy

Stage 4 = chemo +- radiotherapy - may involve immunotherapy

23
Q

SCLC treatment

A

Palliative chemo (cisplatin)

Limited stage = radical RT + chemo

Surgery not an option

Denosumab for bone mets

24
Q

Local complications of lung cancer

A

Recurrent laryngeal nerve palsy

SVC obstruction

Horners syndrome

Rib erosion Pericarditis AF MSCC

25
Q

How to place a chest drain

A

Triangle of safety

Anterior border = lateral edge of pec major

Lateral border = lateral edge of latissimus dorsi I

nferior border = line of 5th IC space

Typical depth = 10cm

Don’t drain more than 500ml at a time

26
Q

Apical tumours cause what specific symptoms?

A

Invade brachial plexus = Horner’s syndrome or Pancoast’s syndrome (pain in nerve roots)

27
Q

What specific histology/ cancer is associated with: Clubbing Sputum production

A

Clubbing = squamous cell

Sputum = bronchio-alveolar

28
Q

Prognosis for SCLC with + without treatment

A

2-4 months no treatment

6-12 months with chemo

29
Q

Prognostic factors

A

Extent of disease

Number of met sites

Performance status

Degree of weight loss

Biochemical abnormalities (high LDH, low sodium/ albumin)

30
Q

What type of RT is used in NSCLC + how often is it given?

A

Continuous hyperfractionated accelerated RT (CHART)

3X a day for 12 days

31
Q

What is targeted chemo in NSCLC?

A

Adenocarcinoma tested for EGFR + ALK mutations

If positive, TKIs used for EGFR mutatuins + Crizotinib for ALK

32
Q

Immunotherapy use in NSCLC

A

Pembrolizumab

When high PDL1 expression - used before or after chemo

33
Q

When is prophylactic cranial RT used?

A

SCLC that has responded to chemo

34
Q

What is SABR?

A

Stereotactic Ablative Body RT

Used for early NSCLC - used to give small number of large doses to a small area